BlackRock
EIKN icon

BlackRock’s Eikon Therapeutics EIKN Stock Holding History

BlackRock’s Portfolio EIKN Stock Details EIKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$39.1M Buy
4,869,276
+587,851
+14% +$5.92M ﹤0.01% 2806
2026
Q2 		$55.9M Buy
4,281,425
+962,046
+29% +$9.8M ﹤0.01% 2615
2026
Q1 		$35.1M Buy
+3,319,379
New +$44.4M ﹤0.01% 2740

Other funds holding EIKN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Merck & Co
Merck & Co Rahway, New Jersey $820M AUM 395.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Regents of the University of California
Regents of the University of California Oakland, California $6.64B AUM 23.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
SCM
Soros Capital Management New York $182M AUM 108.83% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $109B AUM 29.28% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return

BlackRock's EIKN Position: Q3 2026 in Review

BlackRock increased its Eikon Therapeutics (EIKN) stake by 14% in Q3 2026, buying an estimated $5.92M and bringing the position to 4,869,276 shares worth $39.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2806.

BlackRock first reported a position in EIKN in Q1 2026 and has held it in 3 quarters since. The position peaked at $55.9M in Q2 2026. 63 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.

  • BlackRock held 4,869,276 shares of Eikon Therapeutics worth $39.1M as of Q3 2026.
  • BlackRock bought 587,851 Eikon Therapeutics shares in Q3 2026, an estimated $5.92M.
  • Eikon Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q3 2026, its #2806 holding.
  • BlackRock first reported a position in Eikon Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • BlackRock's Eikon Therapeutics position peaked at $55.9M in Q2 2026.
  • 63 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.

Based on BlackRock's 13F filing for Q3 2026, filed 13 Nov 2026.